These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 31242441)

  • 21. A Qualitative Study Exploring Contraceptive Practices and Barriers to Long-Acting Reversible Contraceptive Use in a Sample of Adolescents Living in the Southern United States.
    Coates C; Gordon CM; Simpson T
    J Pediatr Adolesc Gynecol; 2018 Dec; 31(6):605-609. PubMed ID: 30012426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors associated with non-utilization of long acting and permanent contraceptive methods among married women of reproductive age in Chencha district, Southern Ethiopia: a case-control study.
    Alamdo AG; Debere MK; Tirfe ZM
    Pan Afr Med J; 2020; 35():109. PubMed ID: 32637007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Women's empowerment and short- and long-acting contraceptive method use in Egypt.
    Samari G
    Cult Health Sex; 2018 Apr; 20(4):458-473. PubMed ID: 28786755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors associated with discussion of sexual activity and contraception in women with HIV.
    Stewart ZA; Shipley K; Spelman T; Giles ML
    J Fam Plann Reprod Health Care; 2016 Jan; 42(1):12-6. PubMed ID: 25900524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors and the choice of long-acting reversible contraception following medical abortion: effect on subsequent induced abortion and unwanted pregnancy.
    Korjamo R; Heikinheimo O; Mentula M
    Eur J Contracept Reprod Health Care; 2018 Apr; 23(2):89-96. PubMed ID: 29537321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postpartum LARC discontinuation and short interval pregnancies among women with HIV: a retrospective 9-year cohort study in South Carolina.
    Lazenby G; Francis E; Brzozowski N; Rucker L; Dempsey A
    Contraception; 2019 Oct; 100(4):279-282. PubMed ID: 31226321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two year continuation rates of contraceptive methods in France: a cohort study from the French national health insurance database.
    Agostini A; Godard C; Laurendeau C; Benmahmoud Zoubir A; Lafuma A; Lévy-Bachelot L; Gourmelen J; Linet T
    Eur J Contracept Reprod Health Care; 2018 Dec; 23(6):421-426. PubMed ID: 30499732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing uptake of long-acting reversible contraception with structured contraceptive counselling: cluster randomised controlled trial (the LOWE trial).
    Emtell Iwarsson K; Envall N; Bizjak I; Bring J; Kopp Kallner H; Gemzell-Danielsson K
    BJOG; 2021 Aug; 128(9):1546-1554. PubMed ID: 33988917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adherence to Recommended Practices for Provision of Long-Acting Reversible Contraception Among Providers in a Large U.S. Health Care System.
    Judge-Golden CP; Wiesenfeld HC; Chen BA; Borrero S
    J Womens Health (Larchmt); 2020 Dec; 29(12):1586-1595. PubMed ID: 32667847
    [No Abstract]   [Full Text] [Related]  

  • 30. Dual method use among long-acting reversible contraceptive users.
    Bernard C; Zhao Q; Peipert JF
    Eur J Contracept Reprod Health Care; 2018 Apr; 23(2):97-104. PubMed ID: 29582687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Provider and Health System Factors Associated with Usage of Long-Acting Reversible Contraception in Adolescents.
    Smith AJB; Harney KF; Singh T; Hurwitz AG
    J Pediatr Adolesc Gynecol; 2017 Dec; 30(6):609-614. PubMed ID: 28502827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contraceptive method mix and preference: A focus on long acting reversible contraception in Urban Cameroon.
    Ajong AB; Njotang PN; Kenfack B; Essi MJ; Yakum MN; Iballa FBS; Mbu ER
    PLoS One; 2018; 13(8):e0202967. PubMed ID: 30138474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Rise of Female Sterilization: A Closer Look at Colombia.
    Folch BM; Betstadt S; Li D; Whaley N
    Matern Child Health J; 2017 Sep; 21(9):1772-1777. PubMed ID: 28795311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adolescents and Long-Acting Reversible Contraception: Lessons from Mexico.
    Saavedra-Avendano B; Andrade-Romo Z; Rodriguez MI; Darney BG
    Matern Child Health J; 2017 Sep; 21(9):1724-1733. PubMed ID: 27150948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discontinuation of long-acting reversible contraception versus short-term hormonal methods in urban Ghana: A pilot longitudinal study.
    Rominski SD; Manu A; Maya E; Morhe ESK; Dalton VK
    Int J Gynaecol Obstet; 2018 Aug; 142(2):235-236. PubMed ID: 29723394
    [No Abstract]   [Full Text] [Related]  

  • 36. Attendance of an Initial Follow-up Visit after Long-Acting Reversible Contraception Insertion and Method Continuation Among Adolescents and Young Adults: A Retrospective Study.
    Bryson AE; Cabral HJ; Coles MS
    J Pediatr Adolesc Gynecol; 2021 Aug; 34(4):525-529. PubMed ID: 33486086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of utilization of long acting reversible contraceptive and associated factors among women of reproductive age in Harar City, Ethiopia.
    Shiferaw K; Musa A
    Pan Afr Med J; 2017; 28():222. PubMed ID: 29629008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association Between Women's Use of Long-Acting Reversible Contraception and Declining Abortion Rates in New Zealand.
    Whitley CE; Rose SB; Sim D; Cook H
    J Womens Health (Larchmt); 2020 Jan; 29(1):21-28. PubMed ID: 31600111
    [No Abstract]   [Full Text] [Related]  

  • 39. Impact of a pay-for-performance scheme for long-acting reversible contraceptive (LARC) advice on contraceptive uptake and abortion in British primary care: An interrupted time series study.
    Ma R; Cecil E; Bottle A; French R; Saxena S
    PLoS Med; 2020 Sep; 17(9):e1003333. PubMed ID: 32925909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prenatal intent and postpartum receipt of long-acting reversible contraception among women receiving medication-assisted treatment for opioid use disorder.
    Kotha A; Chen BA; Lewis L; Dunn S; Himes KP; Krans EE
    Contraception; 2019 Jan; 99(1):36-41. PubMed ID: 30114393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.